What is STASON PHARMACEUTICALS?
STASON PHARMACEUTICALS is a US-based global pharmaceutical entity with a specialized focus on oncology, renal, and orphan indications. The company offers comprehensive contract development and manufacturing organization (CDMO) services, including analytical testing and contract manufacturing, catering to drug-development firms. Their capabilities extend to high potency product production and handling potent compounds within high containment facilities, reflecting over 26 years of experience in the generic market and a robust global distribution network. Stasonpharma has also diversified into consumer supplement products.
How much funding has STASON PHARMACEUTICALS raised?
STASON PHARMACEUTICALS has raised a total of $931K across 2 funding rounds:
Debt
$350K
Debt
$581K
Debt (2020): $350K with participation from PPP
Debt (2021): $581K led by PPP
What's next for STASON PHARMACEUTICALS?
The recent major strategic investment signals a period of accelerated growth and potential expansion for STASON PHARMACEUTICALS. This capital infusion is likely to bolster their CDMO services, enhance their capabilities in handling potent compounds, and potentially drive further development in their specialized therapeutic areas. The company's established footprint in generics and its global reach position it for continued success and strategic partnerships within the pharmaceutical industry.
See full STASON PHARMACEUTICALS company page
